Press Release|

Groundbreaking ceremony of SHL Group new site

Groundbreaking Image Resize 800x480

With the rapid growth of SHL Group and along with new innovations and technologies developed for pen and autoinjectors, the Taoyuan facility requires expansion of space and thus will be relocating to a new site in Nankan, Taoyuan. Construction started in Q4 of 2015.

In Q1 2018, all administrative offices and parts of the production will be relocated to the new site. The ground level has 12,349m2 area of space, to which a 7-stories high office-and manufacturing building with 62,603m2 total floor space is to be built on. The new facility will help SHL Group increase production capacity, improve efficiency, and raise overall manufacturing quality. This step will open new opportunities for implementing the latest manufacturing technologies.

To mark this special event, the official groundbreaking is set to be on the morning of February 2, 2016. President of SHL Group Roger Samuelsson will be present, along with the SHL Group’s senior executives such as Managing Director of Taiwan, Ulrich Faessler; Managing Director of US, Peter Noolandi; Executive VP of Commercial Operations & Business Development, Mats Persson; VP of Research & Development, Frank Isaksson; Executive VP of SHL Ventures, Stefan Ahlquist; VP of Quality Assurance & Regulatory Affairs, Shelley Chew, and VP of Supply Chain & Business Excellence, Richard Koch.

According to a recent industry report, the autoinjector market will reach US$2.5 billion globally in 2020. Autoinjectors have emerged as one of the fastest growing drug delivery solutions, driven by factors such as their ease of self-administration, allowance for at-home drug administration, decreased hospital visits (thereby reducing the cost of health care), and others. Commenting on this expansion, CEO and President of SHL Group, Roger Samuelsson states: “Customer needs have always been one of the top priorities of SHL Group. Every strategy that we make, we hope to exceed customer expectations. To meet the needs of a growing market for pen and autoinjectors, we must constantly invest in more advanced equipment and expand our production capacity.”

SHL Group keeps customer’s best interest at heart and with the expansion comes improved facility, products, and services.

Groundbreaking Ceremony information:

Date: 2 February 2016 (Tue)
Time: 10:30-14:00
Place: No. 44-1, Liufu Rd., Luzhu Dist., Taoyuan City 338, Taiwan (ROC)

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.  ​

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.​

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com

Share:

Related News